SAN FRANCISCO, Nov. 19, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and...
Hence then, the article about ardent health ardt faces investor scrutiny amid problems estimating collection of accounts receivable disclosure drives stock down 33 hagens berman was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman )
Also on site :
- Court rules Belgium had no right to withhold Russian bank’s assets
- Fired ‘Shrinking’ Crew Member Accuses Warner Bros TV Of Doing Nothing Over Sexual Harassment By EP; Being Scapegoated After Complaining
- Push for AI regulation mounts as talk of AI’s ‘existential’ risks go mainstream. But Trump resists calls for a slowdown